Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study.

Carlo J IasellaMadeline S KreiderLin HuangJames C CoonsJames M Stevenson

Published in: Clinical drug investigation (2019)

SSRI use was associated with a significant decrease in MACE rates compared with patients receiving mirtazapine. Bleeding risk was not affected by either antidepressant treatment. SSRIs may have cardioprotective benefits compared with mirtazapine.

Keyphrases

percutaneous coronary intervention
atrial fibrillation
acute coronary syndrome
coronary artery disease
acute myocardial infarction
st segment elevation myocardial infarction
major depressive disorder
st elevation myocardial infarction
coronary artery bypass grafting
antiplatelet therapy